XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 126,640 $ 0 $ 1,821,731 $ (2,067) $ (1,693,024)
Beginning balance (in shares) at Dec. 31, 2022   3,837      
Issuance of common stock through ATM facilities, net of commissions and offering costs, value 2,172 $ 0 2,172    
Issuance of common stock through ATM facilities, net of commissions and offering costs, shares   122      
Exercise of pre-funded warrants, shares   116      
RSU settlements, net of shares withheld (94)   (94)    
RSU settlements, net of shares withheld, shares   147      
Issuance of common stock pursuant to employee stock awards 928   928    
Issuance of common stock pursuant to employee stock awards, shares   36      
Stock-based compensation expense 45,386   45,386    
Net Income (Loss) (276,126)       (276,126)
Unrealized gain (loss) on available-for-sale securities 1,863     1,863  
Ending balance at Dec. 31, 2023 (99,231) $ 0 1,870,123 (204) (1,969,150)
Ending balance (in shares) at Dec. 31, 2023   4,258      
Issuance of common stock through ATM facilities, net of commissions and offering costs, value 9,312   9,312    
Issuance of common stock through ATM facilities, net of commissions and offering costs, shares   493      
Exercise of pre-funded warrants, shares   9      
RSU settlements, net of shares withheld (7)   (7)    
RSU settlements, net of shares withheld, shares   314      
Issuance of common stock pursuant to employee stock awards 230   230    
Issuance of common stock pursuant to employee stock awards, shares   26      
Issuance of pre-funded warrants to purchase common stock through a registered direct offering, net of offering costs of $177, Shares   759      
Issuance of pre-funded warrants to purchase common stock through a registered direct offering, net of offering costs of $397 50,603 $ 1 50,602 0 0
Stock-based compensation expense 27,001   27,001    
Net Income (Loss) (85,403)       (85,403)
Unrealized gain (loss) on available-for-sale securities 212     212  
Ending balance at Dec. 31, 2024 $ (97,283) $ 1 $ 1,957,261 $ 8 $ (2,054,553)
Ending balance (in shares) at Dec. 31, 2024   5,859